Pricing Log in Create free account

Haemonetics Corporation (HAE) vs Insulet Corporation (PODD)

Haemonetics Corporation and Insulet Corporation are both Medical Devices companies. Insulet Corporation is the larger, with a market value of $9.6B against $5.5B — 1.7× the size. Insulet Corporation trades at the lower P/E: 26.4× against 57.7×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 0.44%. Insulet Corporation has the higher net margin (12.3% vs 7.12%) and the higher return on invested capital (17.6% vs 5.62%). Across the 22 metrics below, Insulet Corporation leads on 16 and Haemonetics Corporation on 6.

Valuation

Metric HAE PODD Medical Devices median
P/E 57.70 26.37 23.22
P/S 3.97 3.20 2.34
P/B 6.41 6.88 2.33
Price to free cash flow 18.34 36.81 23.72
EV/EBITDA 23.05 16.57 11.54
EV/Sales 4.67 3.34 2.24
Earnings yield 1.73% 3.79% (10.09%)
Free cash flow yield 5.45% 2.72% (8.47%)

Profitability

Metric HAE PODD Medical Devices median
Gross margin 59.03% 71.07% 56.01%
Operating margin 11.86% 16.89% (15.03%)
Net margin 7.12% 12.29% (20.40%)
Free cash flow margin 21.64% 8.70% (7.24%)
Return on equity 11.20% 26.02% (15.32%)
Return on assets 3.99% 11.31% (19.72%)
Return on invested capital 5.62% 17.56% (10.33%)

Growth

Metric HAE PODD Medical Devices median
Revenue growth (TTM) 0.44% 29.41% 8.80%
EPS growth (last fiscal year) (38.07%) (39.79%) 29.03%
Revenue growth, 5-year CAGR 8.91% 24.53% 15.47%
Net income growth, 5-year CAGR 4.13% 105.15% 0.00%

Health

Metric HAE PODD Medical Devices median
Debt to equity 1.40 0.67 0.07
Current ratio 3.08 2.48 2.50
Net debt to EBITDA 3.55 0.41 0.49

Dividend

Metric HAE PODD Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric HAE PODD Medical Devices median
Market cap 5.52b 9.62b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack